A small-molecule degrader selectively inhibits the growth of ALK-rearranged lung cancer with ceritinib resistance
Summary: Anaplastic lymphoma kinase (ALK) is a highly responsive therapeutic target for ALK-rearranged non-small cell lung cancer (NSCLC). However, patients with this cancer invariably relapse because of the development of ALK inhibitor resistance resulting from mutations within the ALK tyrosine kin...
Main Authors: | Xin Li, Zixiong Wang, Chao Chen, Fan Yang, Ping Liu, Shu Fang, Bin Wang, Shi Chen, Xinjian Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004224002360 |
Similar Items
-
Diffusion of small molecule drugs is affected by surface interactions and crowder proteins
by: Debabrata Dey, et al.
Published: (2022-10-01) -
Structure-affinity and structure-residence time relationships of macrocyclic Gαq protein inhibitors
by: Jan H. Voss, et al.
Published: (2023-04-01) -
Caged-carvedilol as a new tool for visible-light photopharmacology of β-adrenoceptors in native tissues
by: Anna Duran-Corbera, et al.
Published: (2022-10-01) -
Profiling of ERBB receptors and downstream pathways reveals selectivity and hidden properties of ERBB4 antagonists
by: Lukša Popović, et al.
Published: (2024-02-01) -
Metformin alleviates hepatic iron overload and ferroptosis through AMPK-ferroportin pathway in HFD-induced NAFLD
by: Fangzhi Yue, et al.
Published: (2023-12-01)